Chase Therapeutics Announces $20 Million Series B Financing to Advance Clinical Trials in Parkinson’s Disease and Major Depressive Disorder

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3naA9Gl
via IFTTT